Literature DB >> 10927165

MR-angiography: the role of contrast agents.

M Goyen1, S G Ruehm, J F Debatin.   

Abstract

Contrast-enhanced 3D MR angiography (MRA) permits comprehensive assessment of the supraaortic arteries as well as the arterial system in the chest, abdomen and lower extremities. 3D MRA combines intravenous injection of a non-nephrotoxic, paramagnetic, extracellular contrast agent that increases the signal intensity of blood by shortening its T1 value with the acquisition of a fast 3D data set. High contrast between the vascular lumen and surrounding tissues, inherent three-dimensionality and the ability to collect image data in the chest and abdomen under apnea conditions all contribute to excellent image quality. This review provides clinical applications of 3D MRA in the chest, abdomen and lower extremities based upon the available literature and several clinical examples.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10927165     DOI: 10.1016/s0720-048x(00)00203-5

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  5 in total

1.  Value of high spatial and high temporal resolution magnetic resonance angiography for differentiation between idiopathic and thromboembolic pulmonary hypertension: initial results.

Authors:  Sebastian Ley; Christian Fink; Julia Zaporozhan; Mathias M Borst; F Joachim Meyer; Michael Puderbach; Monika Eichinger; Christian Plathow; Ekkehard Grünig; Karl-Friedrich Kreitner; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2005-07-22       Impact factor: 5.315

2.  Total-body 3D magnetic resonance angiography influences the management of patients with peripheral arterial occlusive disease.

Authors:  Mathias Goyen; Christoph U Herborn; Knut Kröger; Stefan G Ruehm; Jörg F Debatin
Journal:  Eur Radiol       Date:  2005-09-21       Impact factor: 5.315

Review 3.  Congenital diseases of the thoracic aorta. Role of MRI and MRA.

Authors:  Vincenzo Russo; Matteo Renzulli; Cesare La Palombara; Rossella Fattori
Journal:  Eur Radiol       Date:  2005-10-26       Impact factor: 5.315

Review 4.  Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis.

Authors:  Gautam Bhave; Julia B Lewis; Sam S Chang
Journal:  J Urol       Date:  2008-07-17       Impact factor: 7.450

Review 5.  Acquired diseases of the thoracic aorta: role of MRI and MRA.

Authors:  Vincenzo Russo; Matteo Renzulli; Katia Buttazzi; Rossella Fattori
Journal:  Eur Radiol       Date:  2005-10-13       Impact factor: 7.034

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.